Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Hey fever! The surprise benefit of allergies

Long-suffering victims of allergies such as asthma and hay fever might enjoy a surprise benefit, according to research led by the University of New South Wales (UNSW).

24 Jul 2008

Tobacco plant vaccine a cure for cancer?

Scientists in the U.S. say the tobacco plant could be used to "grow" key components of a cancer vaccine; they suggest that the same plant which is responsible for causing cancer may offer a way to treat the disease.

22 Jul 2008

First human tests of an injectable vaccine grown in genetically engineered plants

Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.

21 Jul 2008

Chemo pill shows promise for advanced lymphoma

A new chemotherapy pill for people with stubborn lymphomas is showing promise in early clinical studies, according to scientists at the University of Rochester's James P. Wilmot Cancer Center. Doctors reported that the drug is halting disease in nearly half of the patients with two forms of lymphoma participating in early clinical trials in Rochester and across the country.

15 Jul 2008

New ovarian stimulation technique helps women restore their fertility following chemotherapy or radiotherapy

Researchers have shown for the first time that it is possible to stimulate a woman's ovaries to produce eggs for collection during the final phase of the menstrual cycle.

7 Jul 2008

Modified chemotherapy regimen promising for lymphoma patients in the developing world

Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.

6 Jul 2008

Cancer cases up but survival more than doubles in breast and bowel cancer

The number of people surviving some of the most common types of cancer for at least five years has doubled since the National Health Service was founded 60 years ago.

3 Jul 2008

Individualized therapies for non-Hodgkin's lymphoma identified with PET

Positron emission tomography (PET) could be an important tool for identifying non-Hodgkin's lymphoma patients who are likely to respond well to treatment with 90 ibritumomab tiuxetan (IT)-the first radioimmunotherapy treatment approved for use by the U.S. Food and Drug Administration, said researchers at the Society of Nuclear Medicine's 55th Annual Meeting.

16 Jun 2008

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen Ltd. announced today the discovery of more than ten novel targets of antibody therapy for various types of solid and hematopoietic cancer.

11 Jun 2008

Arthritis drugs used in children to be investigated because of cancer link

Authorities in the United States are investigating certain types of drugs used to treat arthritis and other conditions.

5 Jun 2008

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with Methotrexate

A chronic, inflammatory disease of unknown origin, rheumatoid arthritis (RA) affects about 1 percent of adults worldwide. Marked by joint destruction, RA often leads to disability and diminished quality of life. It can also lead to an early death from cancer.

3 Jun 2008

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

Adults who survived childhood Hodgkin's Lymphoma should be especially vigilant about cancer and cardiovascular screenings, according to researchers from Wake Forest University Baptist Medical Center and colleagues.

2 Jun 2008

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

1 Jun 2008

Study finds increased risk of some cancers among HIV-positive people in U.S.

HIV-positive people in the U.S., many of whom are living longer because of antiretroviral drugs, are at an increased risk for certain types of cancers, according to a study published Tuesday in the Annals of Internal Medicine, Reuters reports.

22 May 2008

Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation

Cancer patients who have been successfully treated for their disease face the prospect of its return if stored ovarian (or testicular) tissue is transplanted back into their bodies without adequate checks, according to researchers at two university hospitals in Israel.

21 Apr 2008

New technique for improving medical diagnosis for cancer patients

Researchers from the UPM's School of Computing and another researcher from Holland’s Radboud University Nijmegen have published an article in the Decision Support Systems journal proposing a technique for improving decision making in medical environments.

18 Apr 2008

Drugs in the pipeline: new therapies that could change treatment strategies

The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.

16 Apr 2008

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Cephalon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved TREANDA (bendamustine hydrochloride) for Injection for the treatment of patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow disease, on March 20, 2008.

7 Apr 2008

Proteolix's Carfilzomib granted orphan drug designation

Proteolix, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to carfilzomib, a selective blocker of proteasome activity for the treatment of multiple myeloma.

3 Apr 2008

New clues to risk of Hodgkin lymphoma discovered

A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12).

2 Apr 2008

Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Hey fever! The surprise benefit of allergies

Tobacco plant vaccine a cure for cancer?

First human tests of an injectable vaccine grown in genetically engineered plants

Chemo pill shows promise for advanced lymphoma

New ovarian stimulation technique helps women restore their fertility following chemotherapy or radiotherapy

Modified chemotherapy regimen promising for lymphoma patients in the developing world

Cancer cases up but survival more than doubles in breast and bowel cancer

Individualized therapies for non-Hodgkin's lymphoma identified with PET

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Arthritis drugs used in children to be investigated because of cancer link

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with Methotrexate

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

Study finds increased risk of some cancers among HIV-positive people in U.S.

Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation

New technique for improving medical diagnosis for cancer patients

Drugs in the pipeline: new therapies that could change treatment strategies

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Proteolix's Carfilzomib granted orphan drug designation

New clues to risk of Hodgkin lymphoma discovered

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in